Home » Topics » Regulatory » Patents

Patents
RSS

Protein MOT12 for diagnosis of IDDM

Dec. 19, 1997

Bayer develops compounds for neurodegenerative disorders

Dec. 19, 1997

Boehringer Mannheim describes antiplatelet agents

Dec. 18, 1997

Several series of integrin antagonists prepared at Searle

Dec. 18, 1997

Antidiabetic agents under development at Takeda

Dec. 18, 1997

U. of Florida prepares new metal chelators

Dec. 18, 1997

More on protein farnesyltransferase inhibitors from Merck & Co.

Dec. 18, 1997

Toa Eiyo discovers new anti-H. pylori agents

Dec. 17, 1997

FA-70D: a new cathepsin inhibitor from Taiho

Dec. 17, 1997

New dihydropyridine derivatives with cardiovascular activity from Mercian

Dec. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...